Myriad Genetics (MYGN) EPS (Weighted Average and Diluted) (2009 - 2026)
Myriad Genetics (MYGN) reported EPS (Weighted Average and Diluted) of -$0.36 for Q1 2026, down 32804.0% year-over-year from N/an in Q1 2025, and down 414.29% quarter-over-quarter from -$0.07 in Q4 2025.
Myriad Genetics (MYGN) EPS (Weighted Average and Diluted) (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.36 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.36, down 32804.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.29 (down 283.04% YoY), and the FY2025 annual result was -$3.95, down 180.14% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$0.36 in Q1 2026 per MYGN's latest filing, from -$0.07 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.0 in Q1 2025 and troughed at -$3.57 in Q2 2025.
- A 5-year average of -$0.6 and a median of -$0.36 in 2026 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) jumped 99.62% in 2025, then plunged 32804.0% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.52 in 2022, then soared by 34.62% to -$0.34 in 2023, then plunged by 38.24% to -$0.47 in 2024, then soared by 85.11% to -$0.07 in 2025, then sank by 414.29% to -$0.36 in 2026.
- Business Quant data shows MYGN's EPS (Weighted Average and Diluted) at -$0.36 in Q1 2026, -$0.07 in Q4 2025, and -$0.29 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.20 |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.61 |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -0.60 |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 8.33 |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | -0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.36 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.29 |
| Jun 30, 2025 | -3.57 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.47 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.41 |
| Mar 31, 2024 | -0.29 |
| Dec 31, 2023 | -0.34 |
| Sep 30, 2023 | -0.75 |
| Jun 30, 2023 | -1.42 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -0.52 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.18 |
| Mar 31, 2022 | -0.26 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | -0.06 |